CHINA PH ARMACY Volume 33，Number 3，February 15，2022 Semimonthly Table of Contents Study on the action framework and key problem of drug safety governance in China
- VernacularTitle:中国药品安全治理的行动框架与关键问题研究
- Author:
Lin WU
1
;
Yongfa CHEN
1
Author Information
1. School of International Medicine and Business，China Pharmaceutical University，Nanjing 211198，China
- Publication Type:Journal Article
- Keywords:
drug safety governance;
cross-sector collaboration;
collaborative governance;
governance modernization
- From:
China Pharmacy
2022;33(3):257-262
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide reference for clarifying the action and development direction of China ’s drug safety governance. METHODS Based on governance theory ，an analysis framework of “Motivation-Sharing-Performance and Feedback ” was established to explain the mechanism of cross-sector collaboration governance of drug safety. By constructing the action framework of national drug safety governance of “3 stages+1 incubation period ”，the connotation of each stage and possible challenges were analyzed ，and improvement suggestions were put forward. RESULTS & CONCUSIONS The obstacles that restricted the effectiveness of drug safety governance in China were mainly due to insufficient information ，resource mobilization and power sharing. Therefore ，the“basic collaboration stage ”should expand the scope of information sharing and involve non-governmental entities ；the“legislative coordination stage ”should focuse on the provision of formal legal systems so that non-governmental forces can play a necessary role in governance activities ；the“deepening of the coordination stage ”should promote the formal integration of social forces into governance system ，and truly realize the transition from “passive participation ” to self-management. It is recommended to continuously improve the construction of drug safety governance system in China in terms of governance norms ，communication mechanisms ，capacity development based on a holistic perspective.
